scholarly article | Q13442814 |
P2093 | author name string | Wim K. Lagrand | |
Martin van der Ent | |||
Maarten L. Simoons | |||
Jin M. Cheng | |||
Peter E. Spronk | |||
Corstiaan A. den Uil | |||
Lucia S. D. Jewbali | |||
P2860 | cites work | EARLY MICROVASCULAR CHANGES IN SEPSIS AND SEVERE SEPSIS | Q58142615 |
‘Death and Life Are in the Power of the Tongue’? | Q58371195 | ||
Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry | Q58371222 | ||
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure | Q61661425 | ||
Impaired sublingual microvascular perfusion during surgery with cardiopulmonary bypass: A pilot study | Q63367555 | ||
Systemic inflammation in patients with heart failure | Q77147307 | ||
Measuring microvascular blood flow in sepsis--a continuing challenge | Q78430721 | ||
Nitroglycerin in septic shock after intravascular volume resuscitation | Q78494402 | ||
Variability in sublingual microvessel density and flow measurements in healthy volunteers | Q83322598 | ||
Low-dose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure | Q83333130 | ||
Early risk stratification of patients with cardiogenic shock complicating acute myocardial infarction who undergo percutaneous coronary intervention | Q83636765 | ||
Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction | Q83995703 | ||
How to evaluate the microcirculation: report of a round table conference | Q22000127 | ||
Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2) | Q28194007 | ||
Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis | Q30493116 | ||
Evaluation of the microcirculation in hypertension and cardiovascular disease | Q33303010 | ||
The mesenteric hemodynamic response to circulatory shock: an overview. | Q34240538 | ||
Central venous-arterial carbon dioxide difference as an indicator of cardiac index | Q34407960 | ||
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology | Q34830023 | ||
Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials | Q34992995 | ||
Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm | Q35160529 | ||
Cardiogenic shock: current concepts and improving outcomes | Q37077213 | ||
The microcirculation in health and critical disease | Q37261691 | ||
The heterogeneity of the microcirculation in critical illness | Q37309569 | ||
Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective | Q37315638 | ||
Coupling microcirculation to systemic hemodynamics | Q37697459 | ||
Measurement of functional microcirculatory geometry and velocity distributions using automated image analysis | Q39626333 | ||
Point-of-care assessment of microvascular blood flow in critically ill patients | Q39890822 | ||
Usefulness of intra-aortic balloon pump counterpulsation in patients with cardiogenic shock from acute myocardial infarction | Q39962044 | ||
Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock | Q40502831 | ||
Base excess and lactate as prognostic indicators for patients admitted to intensive care | Q40716119 | ||
Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries | Q44617277 | ||
Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial | Q44652413 | ||
Microvascular alterations in patients with acute severe heart failure and cardiogenic shock | Q44703478 | ||
Sidestream Dark Field (SDF) imaging: a novel stroboscopic LED ring-based imaging modality for clinical assessment of the microcirculation. | Q45955921 | ||
Preserved cerebral microcirculation during cardiogenic shock. | Q45987016 | ||
Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction | Q46925513 | ||
Do all nonsurvivors of cardiogenic shock die with a low cardiac index? | Q47398169 | ||
Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels | Q47966349 | ||
Mechanical circulatory support devices improve tissue perfusion in patients with end-stage heart failure or cardiogenic shock. | Q50598610 | ||
Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. | Q51683065 | ||
Dose-dependent benefit of nitroglycerin on microcirculation of patients with severe heart failure. | Q51817705 | ||
Echocardiographic Predictors of Survival and Response to Early Revascularization in Cardiogenic Shock | Q57913994 | ||
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cardiogenic shock | Q2477062 |
acute myocardial infarction | Q18558122 | ||
P304 | page(s) | 3032-3039 | |
P577 | publication date | 2010-09-09 | |
P1433 | published in | European Heart Journal | Q2286839 |
P1476 | title | Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock | |
P478 | volume | 31 |
Q64126368 | Alternatives to the Swan–Ganz catheter |
Q93055213 | Association of Hyperhomocysteinemia with Increased Coronary Microcirculatory Resistance and Poor Short-Term Prognosis of Patients with Acute Myocardial Infarction after Elective Percutaneous Coronary Intervention |
Q26742020 | Cardiogenic Shock: Failure of Oxygen Delivery and Oxygen Utilization |
Q37969891 | Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy |
Q35993544 | Cellular responses to mild heat stress |
Q57178023 | Comprehensive in-hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of C |
Q36073179 | Conjunctival microcirculatory blood flow is altered but not abolished in brain dead patients: a prospective observational study |
Q33989560 | Conventional hemodynamic resuscitation may fail to optimize tissue perfusion: an observational study on the effects of dobutamine, enoximone, and norepinephrine in patients with acute myocardial infarction complicated by cardiogenic shock |
Q37731473 | Endoplasmic reticulum stress is involved in cardiac damage and vascular endothelial dysfunction in hypertensive mice. |
Q95940938 | Epidemiology, Pathophysiology and Contemporary Management of Cardiogenic Shock - A position statement from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) |
Q47162974 | Functional evaluation of sublingual microcirculation indicates successful weaning from VA-ECMO in cardiogenic shock |
Q97544759 | Hemodynamic monitoring in patients with venoarterial extracorporeal membrane oxygenation |
Q38258697 | Impact of intravenous nitroglycerin in the management of acute decompensated heart failure |
Q86701169 | Increased Thyroxin During Therapeutic Hypothermia Predicts Death in Comatose Patients After Cardiac Arrest |
Q24201225 | Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome |
Q35568347 | Intraaortic balloon counterpulsation and microcirculation in cardiogenic shock complicating myocardial infarction: an IABP-SHOCK II substudy |
Q38365652 | Is there a role for invasive hemodynamic monitoring in acute heart failure management? |
Q37208712 | Is there light at the end of the tunnel?-new perspectives in ECMO survival. |
Q54985572 | MicroDAIMON study: Microcirculatory DAIly MONitoring in critically ill patients: a prospective observational study. |
Q27303588 | Microcirculatory blood flow during cardiac arrest and cardiopulmonary resuscitation does not correlate with global hemodynamics: an experimental study |
Q26798312 | Microcirculatory dysfunction and resuscitation: why, when, and how |
Q38029553 | Monitoring the microcirculation |
Q26851227 | Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock |
Q49927564 | Predictors of Outcomes in Myocardial Infarction and Cardiogenic Shock |
Q90842218 | Pulmonary artery catheter use in acute myocardial infarction-cardiogenic shock |
Q90149292 | Red Blood Cell Distribution Width Is Associated with All-Cause Mortality in Critically Ill Patients with Cardiogenic Shock |
Q44758791 | Skeletal muscle oxygen saturation (StO2) measured by near-infrared spectroscopy in the critically ill patients. |
Q55347703 | Skin microcirculatory reactivity assessed using a thermal challenge is decreased in patients with circulatory shock and associated with outcome. |
Q39607860 | Study Design of the Microcirculatory Shock Occurrence in Acutely Ill Patients (microSOAP): an International Multicenter Observational Study of Sublingual Microcirculatory Alterations in Intensive Care Patients |
Q35610172 | Sublingual tissue perfusion improves during emergency treatment of acute decompensated heart failure |
Q36547176 | The Human Microcirculation: Regulation of Flow and Beyond |
Q27314786 | The acute phase of experimental cardiogenic shock is counteracted by microcirculatory and mitochondrial adaptations |
Q92158475 | Therapeutic Advances in the Management of Cardiogenic Shock |
Q24187672 | Vasopressors and predominantly vasoconstrictive drugs for acute myocardial infarction complicated by cardiogenic shock |
Q48543645 | Vasopressors for acute myocardial infarction complicated by cardiogenic shock |
Q35010187 | Visualizing the cortical microcirculation in patients with stroke |
Q37966024 | Year in review 2010: Critical Care--Cardiology |
Q87623789 | [Assessment of microcirculation in critically ill patients] |
Q87981965 | [Cardiac support and replacement systems] |
Q86863915 | [Mechanical support in cardiogenic shock] |
Search more.